Ductal adenocarcinoma is the most common primary malignancy of the pancreas, accounting for about 80% of malignant pancreatic tumors. It is a highly aggressive tumor with an overall 5-year survival rate less than 5%. Prognosis and treatment depend on whether the tumor is resectable or non-resectable, which mostly depends on the time of diagnosis
Ductal Adenocarcinoma
Mirko D’Onofrio
;Riccardo De Robertis
;Alessandro Beleù;Luca Geraci
;Luisa Tomaiuolo
;Giovanni Morana
;
2022-01-01
Abstract
Ductal adenocarcinoma is the most common primary malignancy of the pancreas, accounting for about 80% of malignant pancreatic tumors. It is a highly aggressive tumor with an overall 5-year survival rate less than 5%. Prognosis and treatment depend on whether the tumor is resectable or non-resectable, which mostly depends on the time of diagnosis
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
indice_ Imaging and Pathology of Pancreatic Neoplasms.pdf
accesso aperto
Descrizione: indice_atlas
Licenza:
Dominio pubblico
Dimensione
231.8 kB
Formato
Adobe PDF
|
231.8 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
